Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
NEXTSTELLIS® oral contraceptive has been nominated for the 2022 prix galien usa award for best pharmaceutical agent
2022-08-02 13:00
MAYNE PHARMA AND GOODRX ANNOUNCE NEW INITIATIVE TO INCREASE AWARENESS OF NEXTSTELLIS® AND EXPAND ACCESS TO BIRTH CONTROL
2022-07-29 13:00
Mayne Pharma and Mithra Announce TGA Approval of NEXTSTELLIS® Oral Contraceptive
2021-11-30 09:18
FDA Approves LEXETTE (R) for Adolescent Plaque Psoriasis
2021-09-21 22:00
Mayne Pharma launches another generic oral contraceptive
2021-03-05 05:34
New Data On Mayne Pharma's Tolsura® (SUBA®-itraconazole) Presented At IDWeek 2020
2020-10-26 12:10
Mayne Pharma Launches Chlorzoxazone Tablet in the United States
2020-07-28 12:02
Mayne Pharma Announces FDA Filing Acceptance of New Drug Application for E4/DRSP in the US
2020-06-24 12:10
Mayne Pharma Executes 20 Year License and Supply Agreement for Novel Oral Contraceptive in Australia
2020-05-28 17:23
Mayne Pharma launches BAC 300 capsules in the United States
2020-05-22 13:44
Mayne Pharma Submits New Drug Application for E4/DRSP to the FDA
2020-04-16 12:30
Mayne Pharma Signs 20-Year Exclusive License and Supply Agreement for Novel Oral Contraceptive in the US
2019-10-02 12:01
FDA Approves SORILUX(R) for Adolescent Plaque Psoriasis
2019-05-22 18:00
FDA approves trade name Lexette(TM) (halobetasol propionate) foam, 0.05%
2019-04-30 22:35
Mayne Pharma launches Lexette (TM) (halobetasol propionate) foam 0.05% in the United States
2019-02-13 20:30
TOLSURA (TM) (SUBA®-itraconazole) Antifungal Capsule Now Available in the United States
2019-01-30 20:30
Mayne Pharma receives FDA approval of Tolsura™ (SUBA®-itraconazole capsules) for the treatment of certain fungal infections
2018-12-12 07:05
Metrics Contract Services Announces Serialization Capabilities at Greenville Site
2018-11-13 04:29
Metrics Contract Services Adds Commercial Gerteis Roller Compaction Capabilities
2018-11-01 20:00
Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio
2018-10-26 12:22
1